David Charles Lubner's Net Worth
$6.38 Million
Who is David Charles Lubner?
David Charles Lubner has an estimated net worth of $6.38 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, Arcellx, Inc., CARGO Therapeutics, Inc., Dyne Therapeutics, Inc., Vor Biopharma Inc., POINT Biopharma Global Inc., Nightstar Therapeutics plc, Gemini Therapeutics, Inc. /DE, and Ra Pharmaceuticals, Inc..
SEC CIK
David Charles Lubner's CIK is 0001572000
Past Insider Trading and Trends
2021 was David Charles Lubner's most active year for acquiring shares with 8 total transactions. David Charles Lubner's most active month to acquire stocks was the month of January. 2015 was David Charles Lubner's most active year for disposing of shares, totalling 12 transactions. David Charles Lubner's most active month to dispose stocks was the month of January. 2020 saw David Charles Lubner paying a total of $499,998.19 for 257,097 shares, this is the most they've acquired in one year. In 2020 David Charles Lubner cashed out on 748,336 shares for a total of $749,856.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
SVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$25.43 | -$332,310.00 | 69.27K |
Scheduled
|
Aug 14
| ||
Form 4
|
—
|
0
|
$26.15 | -$341,622.09 | 69.27K |
Scheduled
|
Jul 14
| ||
Form 4
| -12.62% | -10.00K |
$21.74 | -$710,200.00 | 69.27K |
Scheduled
|
Jun 12 - Jun 15
| ||
Form 4
|
—
|
0
|
$20.66 | -$558,750.00 | 79.27K |
Scheduled
|
May 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| -14.71% | -13.53K |
$12.51 | -$169,260.30 | 78.46K |
Scheduled
|
Jun 17
| ||
Form 4
| -4.67% | -4.51K |
$13.65 | -$61,561.50 | 91.99K |
Scheduled
|
Mar 6
| ||
Form 4
| -4.46% | -4.51K |
$13.92 | -$62,723.52 | 96.5K |
Scheduled
|
Feb 12
| ||
Form 4
| +348.01% | 78.46K |
$7.90 | -$1,741.55 | 101.01K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| +38.41% | 10.3K |
—
|
—
| 37.1K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcellx, Inc. (ACLX) Snapshot price: $66.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 21.66K |
—
|
—
| 21.66K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CARGO Therapeutics, Inc. (CRGX) Snapshot price: $22.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 53.63K |
—
|
—
| 53.63K |
Jul 31 - Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vor Biopharma Inc. (VOR) Snapshot price: $2.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||